Sao Paulo's Butantan biomedical institute announced on Friday it is developing a "100 percent Brazilian" vaccine against COVID-19 and expects to start using it in July.
Mar 26, 2021
0
9
Three-dimensional, or volumetric, images are widely used in medical imaging. Such images faithfully represent the 3D spatial relationships present in the body. Yet 3D images are typically displayed on a two-dimensional monitor, ...
Mar 25, 2021
0
2
Recent studies have shown that immune response plays a central role in the severity of COVID-19. Understanding the immune responses generated as the disease progresses is therefore key to determining which patients are at ...
Mar 5, 2021
0
4
QIMR Berghofer researchers have discovered some of the ways COVID-19 damages the heart, and identified a class of drugs that could potentially protect or reverse this cardiac injury.
Mar 4, 2021
0
9
Researchers at Mayo Clinic have combined results from a functional test measuring the effect of inherited variants in the BRCA2 breast and ovarian cancer gene with clinical information from women who received genetic testing ...
Feb 19, 2021
0
41
A test that monitors blood levels of DNA fragments released by dying tumor cells may serve as an accurate early indicator of treatment success in people in late stages of one of the most aggressive forms of skin cancer, a ...
Feb 12, 2021
0
77
A new discovery by researchers from Ben-Gurion University of the Negev (BGU) and its affiliated Soroka University Medical Center shows that medical cannabis may reduce blood pressure in older adults.
Feb 8, 2021
1
449
There is an impassioned debate taking place in medicine on whether race-based considerations should be a factor in research, diagnoses, or treatments. Those on one side assert that race should be ignored entirely because ...
Feb 3, 2021
0
4
The Canadian Neuromuscular Disease Registry (CNDR) was launched in 2010 to increase efficient patient access to cutting-edge research and clinical trials, to increase understanding of the natural history and epidemiology ...
Feb 2, 2021
0
2
The British government has exercised an option to buy 40 million more doses of a COVID-19 vaccine being developed by the French-Austrian group Valneva for delivery next year, the company said Monday.
Feb 1, 2021
0
2
